powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1083065643
Laura Mcgarry
DO
Urology
Philadelphia,
PA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (4)
CCN 310011
Hospital
CCN 310014
Hospital
CCN 310047
Hospital
CCN 310113
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
636
Beneficiaries
—
Total drug cost
$253K
Distinct drugs
18
Brand share
47.5%
Top prescribed drugs
Tamsulosin Hcl
125 claims
Vibegron
110 claims
Oxybutynin Chloride
61 claims
Mirabegron
51 claims
Cefdinir
46 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
23.7
Cost
80.7
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$755
Payment records
21
By payment type
Food and Beverage
$755
Top paying entities
Food and Beverage
$755
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,011
Unique beneficiaries
—
Total services
1,150
Distinct HCPCS
23
Medicare payment
$89K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 416 Urology providers in PA — above median (cohort median 1,556).